Enhanced neurogenesis has been reported in the hippocampus of patients with Alzheimer’s disease (AD), the most common neurodegenerative disorder characterized with amyloid-β (Aβ) aggregation, tau hyperphosphorylation, and progressive neuronal loss. Previously we reported that tau phosphorylation played an essential role in adult hippocampal neurogenesis, and activation of glycogen synthase kinase (GSK-3), a crucial tau kinase, could induce increased hippocampal neurogenesis. In the present study, we found that treatment of D-galactose rats with Puerarin could significantly improve behavioral performance and ameliorate the enhanced neurogenesis and microtubule-associated protein tau hyperphosphorylation in the hippocampus ofD-galactose rat brains. FGF-2/GSK-3 signaling pathway might be involved in the effects of Puerarin on hippocampal neurogenesis and tau hyperphosphorylation. Our finding provides primary in vivo evidence that Puerarin can attenuate AD-like enhanced hippocampal neurogenesis and tau hyperphosphorylation. Our finding also suggests Puerarin can be served as a treatment for age-related neurodegenerative disorders, such as AD.
CrewsL, MasliahE (2010) Molecular mechanisms of neurodegeneration in Alzheimer’s disease. Hum Mol Genet19, R12–R20.
2.
JinK, PeelAL, MaoXO, XieL, CottrellBA, HenshallDC, GreenbergDA (2004) Increased hippocampal neurogenesis in Alzheimer’s disease. Proc Natl Acad Sci U S A101, 343–347.
3.
PerryEK, JohnsonM, EkonomouA, PerryRH, BallardC, AttemsJ (2012) Neurogenic abnormalities in Alzheimer’s disease differ between stages of neurogenesis and are partly related to cholinergic pathology. Neurobiol Dis47, 155–162.
4.
DonovanMH, YazdaniU, NorrisRD, GamesD, GermanDC, EischAJ (2006) Decreased adult hippocampal neurogenesis in the PDAPP mouse model of Alzheimer’s disease. J Comp Neurol495, 70–83.
5.
MuY, GageFH (2011) Adult hippocampal neurogenesis and its role in Alzheimer’s disease. Mol Neurodegener6, 85.
6.
JinK, GalvanV, XieL, MaoXO, GorostizaOF, BredesenDE, GreenbergDA (2004) Enhanced neurogenesis in Alzheimer’s disease transgenic (PDGF-APPSw, Ind) mice. Proc Natl Acad Sci U S A101, 13363–13367.
7.
YuY, HeJ, ZhangY, LuoH, ZhuS, YangY, ZhaoT, WuJ, HuangY, KongJ, TanQ, LiXM (2009) Increased hippocampal neurogenesis in the progressive stage of Alzheimer’s disease phenotype in an APP/PS1 double transgenic mouse model. Hippocampus19, 1247–1253.
8.
Lopez-ToledanoMA, ShelanskiML (2007) Increased neurogenesis in young transgenic mice overexpressing human APP(Sw, Ind). J Alzheimers Dis12, 229–240.
9.
HaugheyNJ, NathA, ChanSL, BorchardAC, RaoMS, MattsonMP (2002) Disruption of neurogenesis by amyloid beta-peptide, and perturbed neural progenitor cell homeostasis, in models of Alzheimer’s disease. J Neurochem83, 1509–1524.
ScharfmanHE, HenR (2007) Neuroscience. Is more neurogenesis always better?. Science315, 336–338.
16.
AkersKG, Martinez-CanabalA, RestivoL, YiuAP, De CristofaroA, HsiangHL, WheelerAL, GuskjolenA, NiiboriY, ShojiH, OhiraK, RichardsBA, MiyakawaT, JosselynSA, FranklandPW (2014) Hippocampal neurogenesis regulates forgetting during adulthood and infancy. Science344, 598–602.
17.
JohnsonGV, StoothoffWH (2004) Tau phosphorylation in neuronal cell function and dysfunction. J Cell Sci117, 5721–5729.
18.
WangJZ, LiuF (2008) Microtubule-associated protein tau in development, degeneration and protection of neurons. Prog Neurobiol85, 148–175.
19.
YuY, RunX, LiangZ, LiY, LiuF, LiuY, IqbalK, Grundke-IqbalI, GongCX (2009) Developmental regulation of tau phosphorylation, tau kinases, and tau phosphatases. J Neurochem108, 1480–1494.
20.
HongXP, PengCX, WeiW, TianQ, LiuYH, YaoXQ, ZhangY, CaoFY, WangQ, WangJZ (2010) Essential role of tau phosphorylation in adult hippocampal neurogenesis. Hippocampus20, 1339–1349.
21.
Fuster-MatanzoA, de BarredaEG, DawsonHN, VitekMP, AvilaJ, HernandezF (2009) Function of tau protein in adult newborn neurons. FEBS Lett583, 3063–3068.
22.
ZhengG, LinL, ZhongS, ZhangQ, LiD (2015) Effects of puerarin on lipid accumulation and metabolism in high-fat diet-fed mice. PLoS One10, e0122925.
23.
ZhouY, XieN, LiL, ZouY, ZhangX, DongM (2014) Puerarin alleviates cognitive impairment and oxidative stress in APP/PS1 transgenic mice. Int J Neuropsychopharmacol17, 635–644.
TianJ, IshibashiK, IshibashiK, ReiserK, GrebeR, BiswalS, GehlbachP, HandaJT (2005) Advanced glycation endproduct-induced aging of the retinal pigment epithelium and choroid: A comprehensive transcriptional response. Proc Natl Acad Sci U S A102, 11846–11851.
26.
WuDM, LuJ, ZhengYL, ZhouZ, ShanQ, MaDF (2008) Purple sweet potato color repairs d-galactose-induced spatial learning and memory impairment by regulating the expression of synaptic proteins. Neurobiol Learn Mem90, 19–27.
27.
ZhuJ, MuX, ZengJ, XuC, LiuJ, ZhangM, LiC, ChenJ, LiT, WangY (2014) Ginsenoside Rg1 prevents cognitive impairment and hippocampus senescence in a rat model of D-galactose-induced aging. PLoS One9, e101291.
28.
HaiderS, LiaquatL, ShahzadS, SadirS, MadihaS, BatoolZ, TabassumS, SaleemS, NaqviF, PerveenT (2015) A high dose of short term exogenous D-galactose administration in young male rats produces symptoms simulating the natural aging process. Life Sci124, 110–119.
29.
HuaX, LeiM, ZhangY, DingJ, HanQ, HuG, XiaoM (2007) Long-term D-galactose injection combined with ovariectomy serves as a new rodent model for Alzheimer’s disease. Life Sci80, 1897–1905.
30.
ZhangXL, AnLJ, BaoYM, WangJY, JiangB (2008) D-galactose administration induces memory loss and energy metabolism disturbance in mice: Protective effects of catalpol. Food Chem Toxicol46, 2888–2894.
31.
KumarA, PrakashA, DograS (2011) Centella asiatica attenuates D-galactose-induced cognitive impairment, oxidative and mitochondrial dysfunction in mice. Int J Alzheimers Dis2011, 347569.
32.
TatebayashiY, IqbalK, Grundke-IqbalI (1999) Dynamic regulation of expression and phosphorylation of tau by fibroblast growth factor-2 in neural progenitor cells from adult rat hippocampus. J Neurosci19, 5245–5254.
33.
TerryRD, PeckA, DeTeresaR, SchechterR, HoroupianDS (1981) Some morphometric aspects of the brain in senile dementia of the Alzheimer type. Ann Neurol10, 184–192.
34.
ChenL, ChaiQ, ZhaoA, ChaiX (1995) [Effect of puerarin on cerebral blood flow in dogs]. Zhongguo Zhong Yao Za Zhi20, 560–562, inside backcover.
35.
WangL, ZhaoA, WangF, ChaiQ, ChaiX (1997) [Protective effect of puerarin on acute cerebral ischemia in rats]. Zhongguo Zhong Yao Za Zhi22, 752–754, 765.
36.
HanJ, WanH, GeL, ZhuZ, GuoY, ZhangY, LiJ (2009) [Protective effect of 3’-methoxy puerarin on cerebral ischemic injury/ reperfusion in rats]. Zhongguo Zhong Yao Za Zhi34, 1422–1425.
37.
HengLS, LanBS, JiaZ, WangPF, FanLY (2009) [Protective effect of puerarin on the secondary spinal cord injury in rats]. Zhong Yao Cai32, 395–397.
38.
ZhangHY, YiXN, LiuYH, LaoML, ZhangXF (2010) [The protective effect of puerarin on Abeta(25-35)-induced PC12 cell injury]. Zhong Yao Cai33, 763–767.
39.
LinF, XieB, CaiF, WuG (2012) Protective effect of Puerarin on beta-amyloid-induced neurotoxicity in rat hippocampal neurons. Arzneimittelforschung62, 187–193.
40.
ZouY, HongB, FanL, ZhouL, LiuY, WuQ, ZhangX, DongM (2013) Protective effect of puerarin against beta-amyloid-induced oxidative stress in neuronal cultures from rat hippocampus: Involvement of the GSK-3beta/Nrf2 signaling pathway. Free Radic Res47, 55–63.
41.
WinocurG, WojtowiczJM, SekeresM, SnyderJS, WangS (2006) Inhibition of neurogenesis interferes with hippocampus-dependent memory function. Hippocampus16, 296–304.
42.
KimJS, LeeHJ, KimJC, KangSS, BaeCS, ShinT, JinJK, KimSH, WangH, MoonC (2008) Transient impairment of hippocampus-dependent learning and memory in relatively low-dose of acute radiation syndrome is associated with inhibition of hippocampal neurogenesis. J Radiat Res49, 517–526.
43.
Suarez-PereiraI, CanalsS, CarrionAM (2015) Adult newborn neurons are involved in learning acquisition and long-term memory formation: The distinct demands on temporal neurogenesis of different cognitive tasks. Hippocampus25, 51–61.
44.
JaholkowskiP, KirykA, JedynakP, Ben AbdallahNM, KnapskaE, KowalczykA, PiechalA, Blecharz-KlinK, FigielI, LioudynoV, Widy-TyszkiewiczE, WilczynskiGM, LippHP, KaczmarekL, FilipkowskiRK (2009) New hippocampal neurons are not obligatory for memory formation; cyclin D2 knockout mice with no adult brain neurogenesis show learning. Learn Mem16, 439–451.
45.
MongiatLA, SchinderAF (2014) Neuroscience. A price to pay for adult neurogenesis. Science344, 594–595.
46.
CameronHA, GloverLR (2015) Adult neurogenesis: Beyond learning and memory. Annu Rev Psychol66, 53–81.
47.
HaggT (2005) Molecular regulation of adult CNS neurogenesis: An integrated view. Trends Neurosci28, 589–595.
48.
BrionJP, OctaveJN, CouckAM (1994) Distribution of the phosphorylated microtubule-associated protein tau in developing cortical neurons. Neuroscience63, 895–909.
49.
BrionJP, SmithC, CouckAM, GalloJM, AndertonBH (1993) Developmental changes in tau phosphorylation: Fetal tau is transiently phosphorylated in a manner similar to paired helical filament-tau characteristic of Alzheimer’s disease. J Neurochem61, 2071–2080.
50.
SchindowskiK, BelarbiK, BrettevilleA, AndoK, BueeL (2008) Neurogenesis and cell cycle-reactivated neuronal death during pathogenic tau aggregation. Genes Brain Behav7 (Suppl 1), 92–100.
51.
HradekAC, LeeHP, SiedlakSL, TorresSL, JungW, HanAH, LeeHG (2015) Distinct chronology of neuronal cell cycle re-entry and tau pathology in the 3xTg-AD mouse model and Alzheimer’s disease patients. J Alzheimers Dis43, 57–65.
52.
TakahashiM, TomizawaK, KatoR, SatoK, UchidaT, FujitaSC, ImahoriK (1994) Localization and developmental changes of tau protein kinase I/glycogen synthase kinase-3 beta in rat brain. J Neurochem63, 245–255.
53.
LeroyK, BrionJP (1999) Developmental expression and localization of glycogen synthase kinase-3beta in rat brain. J Chem Neuroanat16, 279–293.
54.
Gomez-PinillaF, CummingsBJ, CotmanCW (1990) Induction of basic fibroblast growth factor in Alzheimer’s disease pathology. Neuroreport1, 211–214.
55.
StopaEG, GonzalezAM, ChorskyR, CoronaRJ, AlvarezJ, BirdED, BairdA (1990) Basic fibroblast growth factor in Alzheimer’s disease. Biochem Biophys Res Commun171, 690–696.
56.
PeiJJ, TanakaT, TungYC, BraakE, IqbalK, Grundke-IqbalI (1997) Distribution, levels, and activity of glycogen synthase kinase-3 in the Alzheimer disease brain. J Neuropathol Exp Neurol56, 70–78.
